Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03685422 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery

StatusActive, Not Recruiting
PhaseNot applicable
Started2019-03-26
View on ClinicalTrials.gov ↗
In the perioperative setting, distraction therapies have been used as a technique to reduce anxiety and pain in the perioperative period. Measures employed in the local restructured hospitals include television, magazines, and newspapers. Tablet-based activity, music and video distraction therapy have also been shown to be useful to reduce preoperative anxiety. The investigators propose a prospective study to implement and evaluate the use of Virtual Reality (VR) in decreasing in anxiety and pain undergoing gynaecological surgery. In the first phase of study, VR will be administered in 110 female adults undergoing day surgery, same-day-admission or in-patient gynecologic surgery in KKH. The VR will be administered using a Samsung Gear VR3 headset fitted with a smartphone. VR images and sound with calming effect will be delivered to the patients for a short duration of up to 25 minutes. This low-intensity activity offers soothing experience to distract the patients from any pain and anxiety. Second phase of study will randomize 110 female adults undergoing gynecologic surgery. Pain and psychological assessment will be conducted after recruitment, and the group assigned to VR group will navigate the VR environment before and after surgery.

Amendment history 2 changes detected by DataLookout

2026-08-08
critical
Primary completion pushed: 2025-12-31 → 2027-05-31
2026-08-08
minor
Completion pushed: 2026-08-31 → 2027-12-31
Trial Details
NCT Number NCT03685422
Lead Sponsor KK Women's and Children's Hospital
Conditions Pain, Postoperative, Anxiety
Enrollment 220 participants
Start Date 2019-03-26
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-07